News

c21641c5f5b4f07ffddd3f6d2e0a4b70499ff842 September 18, 2025

Contribution to the CCQM workshop: Standardized pathogen measurements

At the CCQM workshop "Towards standardized pathogen measurements", Annemarie Martin (project leader dPCR) presented our approach for the reliable quantification of control samples for virus genome detection - as a basis for the performance evaluation of laboratories in EQA schemes and for standardization in virus diagnostics.

Read more
b2266ed2aedd9bd96642b9c4148c25c3b6eb993b September 18, 2025

B2Run 2024: GBD Team Reaches the Berlin Olympic Stadium Finish

With strong team spirit, great weather and a memorable finish in Berlin’s Olympic Stadium, our GBD running team proudly took part in B2Run 2024 – an all-round successful event.

Read more
5966e68bd906309b7f2522dc499c9d93ce04e197 September 18, 2025

ESCV 2024: Exchange with partners and customers

At ESCV 2024, we focussed on personal exchange: an important meeting place to meet colleagues, partners and customers, deepen discussions and gain new impetus for cooperation in quality and safety-critical areas.

Read more
b135d72c83234800d00f64380f00f7ae5c3f4f03 September 18, 2025

DailyCheck introduced: new cooperation & third-party controls for Seegene tests

On 16/17 September 2024 in Leipzig, we presented our new cooperation and the DailyCheck product line. DailyCheck enables users of Seegene tests to access independent control samples from a third-party provider; panels for gastro pathogens are currently available and can be obtained from Seegene.

Read more
27c247576c07fc61da8907187d403a9f49fa0c8d September 18, 2025

AAL Düsseldorf 2024: GBD with stand and lecture on external quality assurance

GBD was represented at the AAL in Düsseldorf on 13/14 September 2024 - with a supervised stand and a much-noticed presentation by Martin Kammel. The focus of the event: external quality assurance and why external quality control is more than just a compulsory programme.

Read more
21a428fab8143bbbdbd30bc70b72c4ea436233f7 September 18, 2025

MDx-days (powered by QIAGEN): Syndromic testing, dPCR & new project ideas

Report from the MDx-days (powered by QIAGEN): The focus was on syndromic testing - opportunities and developments - as well as highlights relating to dPCR. The aim is to utilise the power of molecular diagnostics to further develop healthcare and achieve better patient outcomes.

Read more